On December 22, 2025, the U.S. Food and Drug Administration officially approved the once-daily oral version of Wegovy (semaglutide 25 mg) as the first ever oral GLP-1 receptor agonist for weight management

Auch diesen Monat habe ich wieder 100 € in mein Aktiendepot gesteckt. Die Wahl fiel mir wieder nicht leicht. Es gibt viele interessante Unternehmen, an deren künftigen Erfolg ich mich gerne beteiligen

Der Hype war ja relativ schnell vorbei. Wie geht es weiter? The hype died down relatively quickly. What's next? Deutsch: english below ⬇️ Steiler Anstieg und dann zurück auf Los? Novo Nordisk, lange Jahre

... Denmark's GDP! 📈 Their shares surged 13% last week due to positive news on obesity drug refunds. A testament to their success, but also a reflection on global financial dynamics. 💊🌍 #NovoNordisk

In our present day of fast life (which ironically is mostly sedentary), and poor diet options, it has become increasingly more difficult to watch weight, and even more difficult to lose it, and one company

Histology images hold great potential as a resource for target and biomarker discovery activities. However, in order to use such complex phenotypic data, it is imperative that robust image analysis tools